Company / CapEx per Share
Phio Pharmaceuticals Corp. CapEx per Share History
FY2012-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.11
FY2020
5-year range
$0.00 / $0.11
FY2016-FY2020
Trend
+636.9%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
CapEx per Share changed +637% YoY in FY2020, a notable deviation from the 6-year average annual change of +852%.
Based on SEC 10-K filings.
0.11 in FY2020 with a 3-year CAGR of +227.0%.
Improved from $0.08 to $0.11 over the past 2 years.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +227.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, capex per share increased 636.9% year-over-year.
- Lowest capex per share in the period was in FY2012.
Company context
Key Data Points
- Altman Z-Score -0.94 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | $0.11 | +636.9% |
| FY2019 | $0.01 | -82.5% |
| FY2018 | $0.08 | +2615.7% |
| FY2017 | $0.00 | -64.7% |
| FY2016 | $0.01 | +207.6% |
| FY2013 | $0.00 | +1799.0% |
| FY2012 | $0.00 | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026